There are 2789 resources available
95P - Optimizing selection of experimental treatment for patients with advanced cancer using whole genome sequencing
Presenter: Melinda Pruis
Session: ePoster Display
96P - Real-world single institution clinical outcome study of the impact of comprehensive genomic profiling (CGP) on targeted therapy selection and cancer patient survival
Presenter: Bhaskara Reddy Madhira
Session: ePoster Display
97P - Comparative serum metabolome analysis as a diagnostic tool in concomitant rheumatic and malignant diseases
Presenter: Dorothea Marx
Session: ePoster Display
98P - A stable NGS method to detect microsatellite instability status across different batches, sequencing platforms and cancer types
Presenter: Chenghong Lin
Session: ePoster Display
99P - The differentially fragmented regions in cell-free DNA of colorectal cancer patients
Presenter: Dmitry Shcherbo
Session: ePoster Display
100P - Characteristics and outcomes of patients (pts) with NTRK fusion-positive (NTRK+) metastatic / locally advanced (LA) solid tumours receiving non-TRK inhibitor (TRKi) standard of care (SoC), and prognostic value of NTRK fusions in clinical practice
Presenter: George Demetri
Session: ePoster Display
216P - Prognostic role of Ki67 cutoff and mPEPI score for neoadjuvant ‘chemotherapy’ in locally advanced HER2-negative ‘luminal’ breast cancer
Presenter: Mutlu Dogan
Session: ePoster Display
217P - The impact of obesity on the survival outcomes of women with breast cancer that achieve pathological complete response
Presenter: Mariana Roman-Zamudio
Session: ePoster Display
218P - Differential effects of estrogen exposure on steroid metabolizing CYP enzyme expression in estrogen receptor alpha versus beta positive breast cancer cell lines
Presenter: Julia Stingl
Session: ePoster Display
219P - Accuracy of MRI to assess response after neoadjuvant chemotherapy according to immunohistochemical breast cancer subtypes: A systematic review and meta-analysis
Presenter: Liselore Maria Janssen
Session: ePoster Display